Stock quote - Summary

Faron Pharmaceuticals
FARN: 140.00 +1.50 ( +1.08 %) delayed: 16:57PM
Bid price 135.00 High price 154.95
Ask price 145.00 Low price 127.00
Open price 140.00 Spread 6.90%
Prev close 140.00 Volume 693,005

Faron Pharmaceuticals - Share price charts

Intraday
Historic - 6 months

Advanced Faron Pharmaceuticals charts >

Faron Pharmaceuticals - Share price information
Name Faron Pharmaceuticals Epic FARN
Activities Faron Pharmaceuticals OY is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy. The Company's first candidate Traumakine, to prevent vascular leakage and organ failures, has completed a Phase III clinical trial in Acute Respiratory Distress Syndrome (ARDS). An additional European Phase II Traumakine trial is underway for the Rupture of Abdominal Aorta Aneurysm (RAAA). Faron's second candidate Clevegen is a ground breaking early clinical anti-Clever-1 antibody. Clevegen has the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development. ISIN FI4000153309
Latest Share Price (p) 140.00 Net Gearing (%) 44.56
Market Capitalisation (pm) 54.51 Gross Gearing (%) 95.39
Shares in issue (m) 39.36 Debt Ratio 83.64
P/E Ratio -2.13 Debt-to-Equity Ratio 0.25
Total dividends per share (p) 0.00 Assets / Equity Ratio 21.68
Dividend Yield (%) 0.00 Price to book value 147.32
Dividend Cover 0.00 ROCE (%) -892.44
Earning per share (p) -65.00 EPS Growth (%) 14.47
52-week high / low (p) 168.00 / 51.00 DPS Growth (%) n/a
Faron Pharmaceuticals - Broker views
Date Broker Recommendation Price Old target price New target price Notes
02 Oct Panmure Gordon Buy - - Reiterates
07 Sep Panmure Gordon Buy - 723.00 Reiterates
06 Sep Panmure Gordon Buy - - Retains
30 Aug Panmure Gordon Buy - - Retains
08 May Panmure Gordon Buy 663.00 663.00 Reiterates

More Faron Pharmaceuticals broker views >

Faron Pharmaceuticals - Director deals
Date Director Type Volume / Price Trade value
21 Jun 2018 Dr Juho Jalkanen Buy 12,000 @ 71.00p £8,520.00
21 Jun 2018 Dr Markku Jalkanen Buy 36,000 @ 71.00p £25,560.00
21 Jun 2018 Yrjo Wichmann Buy 5,200 @ 67.00p £3,484.00
21 Jun 2018 Matti Manner Buy 23,400 @ 56.00p £13,104.00
21 Jun 2018 Dr Frank Armstrong Buy 13,300 @ 75.00p £9,975.00

More Faron Pharmaceuticals director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.